NCT01897597View on ClinicalTrials.gov

Clinical Drug Trial in Healthy Male Subjects to Determine and Compare the Blood Concentrations of BI 144807 Following Administration as Oral Solution and Tablet Under Fasted and Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Healthy
Interventions
DRUG

BI 144807 high dose

oral solution

DRUG

BI 144807 intermediate dose

tablet

DRUG

BI 144807 intermediate dose

tablet

DRUG

BI 144807 intermediate dose

tablet

DRUG

BI 144807 intermediate dose

tablet

DRUG

BI 144807 intermediate dose

oral solution

DRUG

BI 144807 high dose

tablet

Trial Locations (1)

Unknown

1313.9.1 Boehringer Ingelheim Investigational Site, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01897597 - Clinical Drug Trial in Healthy Male Subjects to Determine and Compare the Blood Concentrations of BI 144807 Following Administration as Oral Solution and Tablet Under Fasted and Fed Conditions | Biotech Hunter | Biotech Hunter